Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
1019 35 |
Ultima descărcare din IBN: 2024-01-16 14:58 |
Căutarea după subiecte similare conform CZU |
616.36-003.826-06-085 (1) |
Patologia sistemului digestiv. Tulburări ale tubului alimentar (1732) |
SM ISO690:2012 LUPAŞCO, Iulianna, DUMBRAVA, Vlada-Tatiana, HAREA, Gheorghe, TOCAN, Alina, URSACHII, Cristina, CEBANU, Ecaterina, RĂILEANU, Ludmila, CUMPĂTĂ, Veronica. Sindromul metabolic și steatoza hepatică. In: Sănătate Publică, Economie şi Management în Medicină , 2016, nr. 4(68), pp. 60-65. ISSN 1729-8687. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Sănătate Publică, Economie şi Management în Medicină | ||||||
Numărul 4(68) / 2016 / ISSN 1729-8687 /ISSNe 2587-3873 | ||||||
|
||||||
CZU: 616.36-003.826-06-085 | ||||||
Pag. 60-65 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
Metabolic syndrome (MS) is a complex of risk factors that occur as a result of the combination of insulin resistance, depositing excess of body fat (visceral abdominal, blood vessels, internal organs including liver and pancreas), with a major impact on cardio-vascular system, frequently accompanied by liver involvement. The aim of this study was to detect the frequency of liver alteration associated with MS, in patients that addressed the consultation of a gastroenterologist. Of 263 patients who were seen by a gastroenterologist, in 85 (32,7%) were diagnosed MS. The average age was 50,95 years, the ratio males: females – 1: 1.02. In 80 (94,12%) patients of the studied group with MS was established hepatic involvement: non-alcoholic fatty liver disease, (NAFLD) – 27 (33,75%) cases, chronic viral infection (B, C, D) in 10 (12,5%) cases, the association of chronic viral infection and liver steatosis – 43 (53,75%) cases. In 5 (5,88%) cases were diagnosed other pathologies of gastrointestinal tract: chronic pancreatitis, chronic cholecystitis, gastroesophageal reflux disease. MS is meeting frequently in patients with hepatic pathology of different etiology. Non-alcoholic liver steatosis is a risk factor commonly associated with MS, therefore the clinician has to be ready in diagnosing this pathology on outpatients level in order to stop the chronic hepatic disease unfavorable evolution and progression. |
||||||
Cuvinte-cheie metabolic syndrome, hepatic steatosis |
||||||
|
Dublin Core Export
<?xml version='1.0' encoding='utf-8'?> <oai_dc:dc xmlns:dc='http://purl.org/dc/elements/1.1/' xmlns:oai_dc='http://www.openarchives.org/OAI/2.0/oai_dc/' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xsi:schemaLocation='http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd'> <dc:creator>Lupaşco, I.A.</dc:creator> <dc:creator>Dumbrava, V.A.</dc:creator> <dc:creator>Harea, G.G.</dc:creator> <dc:creator>Tocan, A.</dc:creator> <dc:creator>Ursachii, C.</dc:creator> <dc:creator>Cebanu, E.C.</dc:creator> <dc:creator>Răileanu, L.</dc:creator> <dc:creator>Cumpătă, V.</dc:creator> <dc:date>2016-08-31</dc:date> <dc:description xml:lang='en'><p><em>Metabolic syndrome (MS) is a complex of risk factors that occur as a result of the combination of insulin resistance, depositing excess of body fat (visceral abdominal, blood vessels, internal organs including liver and pancreas), with a major impact on cardio-vascular system, frequently accompanied by liver involvement. The aim of this study was to detect the frequency of liver alteration associated with MS, in patients that addressed the consultation of a gastroenterologist. Of 263 patients who were seen by a gastroenterologist, in 85 (32,7%) were diagnosed MS. The average age was 50,95 years, the ratio males: females </em><em>– </em><em>1: 1.02. In 80 (94,12%) patients of the studied group with MS was established hepatic involvement: non-alcoholic fatty liver disease, (NAFLD) </em><em>– </em><em>27 (33,75%) cases, chronic viral infection (B, C, D) in 10 (12,5%) cases, the association of chronic viral infection and liver steatosis </em><em>– </em><em>43 (53,75%) cases. In 5 (5,88%) cases were diagnosed other pathologies of gastrointestinal tract: chronic pancreatitis, chronic cholecystitis, gastroesophageal reflux disease. MS is meeting frequently in patients with hepatic pathology of different etiology. Non-alcoholic liver steatosis is a risk factor commonly associated with MS, therefore the clinician has to be ready in diagnosing this pathology on outpatients level in order to stop the chronic hepatic disease unfavorable evolution and progression</em><em>.</em> </p></dc:description> <dc:description xml:lang='ru'><p><em>Метаболический синдром (МС) представляет собой комплекс факторов риска, которые возникают как результат резистентности тканей к инсулину, избыточного жироотложения (увеличение массы висцерального жира, отложения на передней брюшной стенке, в сосудах, во внутренних органах, включая печень и поджелудочную железу), с негативным воздействием на сердечно-сосудистую систему, что зачастую сопровождается вовлечением печени в патологический процесс. Целью данного исследования было выявление частоты ассоциированного с МС поражения печени среди пациентов, обратившихся за консультацией к врачу-гастроэнтерологу. Среди 263 пациентов, осмотренных гастроэнтерологом, у 85 (32,7%) был констатирован диагноз МС. Средний возраст составил 50,95 лет. Соотношение по полам мужчин и женщин составило 1:1,02. У 80 (94,12%) пациентов в исследуемой группе с МС было выявлено поражение печени: </em><em>неалкогольная жировая болезнь печени – 27 (</em><em>33,75%</em><em>) случаев, хронические вирусные инфекции (</em><em>B</em><em>, </em><em>C</em><em>, </em><em>D</em><em>) – в 10 (</em><em>12,5%</em><em>) случаях, комбинация хронической вирусной инфекции и стеатоза печени – в 43 </em><em>(53,75%) случаях. В 5 (5,88%) случаях были диагностированы другие патологии желудочнокишечного тракта: хронический панкреатит, хронический холецистит, гастроэзофагеальный рефлюкс. МС встречается часто среди пациентов с печеночной патологией различной этиологии. Неалкогольная жировая болезнь печени это фактор риска, достаточно часто встречающийся совместно с МС. Таким образом, клиницисты должны быть готовы диагностировать данную патологию при амбулаторном обследовании, чтобы своевременно предотвратить возможную неблагоприятную эволюцию</em></p></dc:description> <dc:source>Sănătate Publică, Economie şi Management în Medicină 68 (4) 60-65</dc:source> <dc:subject>metabolic syndrome</dc:subject> <dc:subject>hepatic steatosis</dc:subject> <dc:title>Sindromul metabolic și steatoza hepatică</dc:title> <dc:type>info:eu-repo/semantics/article</dc:type> </oai_dc:dc>